PQ 224
224. Deputy Charlie McConalogue asked the Minister for Health the status of a meeting which was scheduled to take place between the manufacturer and the HSE (details supplied) following the HSE's assessment of the drug Respreeza; and if he will make a statement on the matter. [6291/17]
Introduced
8 February 2017
Last action
8 February 2017 · Medical Products
Status
written
Sponsors
McConalogue, Charlie.
Subjects
Discovery layer
Source updated
8 February 2017
Summary
224. Deputy Charlie McConalogue asked the Minister for Health the status of a meeting which was scheduled to take place between the manufacturer and the HSE (details supplied) following the HSE's assessment of the drug Respreeza; and if he will make a statement on the matter. [6291/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 February 2017
Medical Products
224. Deputy Charlie McConalogue asked the Minister for Health the status of a meeting which was scheduled to take place between the manufacturer and the HSE (details supplied) following the HSE's assessment of the drug Respreeza; and if he will make a statement on the matter. [6291/17]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medical Products
Medical Products
xml · EN · 8 February 2017
Sponsors
- McConalogue, Charlie. · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-02-08/224/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-02-08/pq_224
- ireland · q-2017-02-08-pq_224 · source updated 8 February 2017